Myoglobin as a model system for designing heme protein based blood substitutes.
about
Nitric-oxide dioxygenase function of human cytoglobin with cellular reductants and in rat hepatocytesDevelopment of recombinant hemoglobin-based oxygen carriersDeterminants of Ligand Affinity and Heme Reactivity in H-NOX DomainsRu-Porphyrin Protein Scaffolds for Sensing O 2Controlling Conformational Flexibility of an O 2 -Binding H-NOX DomainPorphyrin π-stacking in a heme protein scaffold tunes gas ligand affinitySignificantly enhanced heme retention ability of myoglobin engineered to mimic the third covalent linkage by nonaxial histidine to heme (vinyl) in synechocystis hemoglobinStraight-chain alkyl isocyanides open the distal histidine gate in crystal structures of myoglobinHemoglobin: a nitric-oxide dioxygenaseHemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.Down selection of polymerized bovine hemoglobins for use as oxygen releasing therapeutics in a guinea pig modelInducible defense mechanism against nitric oxide in Candida albicans.Sulfide-binding hemoglobins: Effects of mutations on active-site flexibility.Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias.Mechanisms of slower nitric oxide uptake by red blood cells and other hemoglobin-containing vesicles.Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems.Allosteric hemoglobin assembly: diversity and similarity.Measurements of nitric oxide on the heme iron and beta-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation.The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin.Structural and thermodynamic consequences of b heme binding for monomeric apoglobins and other apoproteins.Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysisIn vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.Combining the influence of two low O2 affinity-inducing chemical modifications of the central cavity of hemoglobinInterfacial and distal-heme pocket mutations exhibit additive effects on the structure and function of hemoglobin.Factors controlling the reactivity of hydrogen sulfide with hemeproteins.Coexpression of human alpha- and circularly permuted beta-globins yields a hemoglobin with normal R state but modified T state propertiesBiological activity of nitric oxide in the plasmatic compartment.Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.Cardiovascular abnormalities in sickle cell disease.New light on NO bonding in Fe(III) heme proteins from resonance Raman spectroscopy and DFT modeling.Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.A "sliding scale rule" for selectivity among NO, CO, and O₂ by heme protein sensors.Vitamin C supplementation influences the antioxidant response and nitric oxide handling of erythrocytes and lymphocytes to diving apnea.Enhanced nitrite reductase activity associated with the haptoglobin complexed hemoglobin dimer: functional and antioxidative implications.Structural dynamics of myoglobin: ligand migration and binding in valine 68 mutants.2017 Military Supplement: Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive.Engineering oxidative stability in human hemoglobin based on the Hb providence (βK82D) mutation and genetic cross-linking.
P2860
Q24601541-E51F36C1-978C-41F7-BD0E-49281C0BD5A3Q27008891-BD2D3BD3-2169-45EF-9C1C-DBE3609DA981Q27658678-5ACCAD21-18C8-434B-9789-0DB96EBB6202Q27660443-CCA6CE6C-02A3-4345-911B-33EF1DD384B7Q27670635-2787A5CE-CDA7-4ADB-8352-3FFC87703A34Q27678947-9BDBD963-8A45-4221-A01F-B46463A3142BQ28651669-1D77A08D-3A10-4789-89E6-A6F872E7CF31Q28656517-26869508-BF30-4200-AB24-35E57EC1F750Q28661723-BC7832C7-F2AB-4C68-8DDB-19CC4805A79CQ34133584-0DF12E8A-F309-42D0-8701-BA16CF09CDDFQ34194945-5CFBDEAD-04A6-4183-962F-369F266C311EQ34360894-8E026CEA-F6E5-4973-928C-5D29C4F933EDQ34984677-BFDF59EE-83DC-417C-9B8F-84CBFBD22467Q35222193-B88AFED1-27CC-44D6-BDF0-DC5AECF6B2FBQ35311913-871A19B7-443A-428D-81EE-63A2C507990AQ35894997-188370FF-B917-4C82-92F8-59E58F0981E9Q36149213-38FBE1FA-8EAC-4B9E-9137-FF7AF922F0B1Q36160714-99BBE4C4-F26B-4049-B93A-A297F4878769Q36648000-A5AD7D73-F9B9-4DB2-AB84-FE4212DC59FAQ36671880-F43E988C-7925-48C5-9100-0F33AC8841D4Q36692610-F5FB1A3E-E975-4767-ACE1-AFCFD33F8A75Q36810287-E28C42F7-0FA6-4928-9FEE-142C06C6E0A0Q36844604-7B8D8923-C133-4FA8-B26D-CDCE7E4DE7D0Q36941158-34CA1925-22A7-48B1-87CC-5FD087936AD5Q36948857-099DA79A-25FF-455C-961F-45143ACCB25EQ37217030-DB73D398-1336-4256-A541-103C5C4280B5Q37273727-0E559310-A216-4BC8-BABD-29B4A859F090Q37301645-CE7128E6-00F2-400E-A9D0-09FF54A351FCQ37388929-D2306A98-D313-4F5A-A8BE-F1965F5E65AFQ37394306-BA90AF05-00D9-488E-AB7B-A70353B22F47Q37435068-34D109A4-4F90-4E65-B190-79EECCB30C94Q40000351-A7944022-547A-430E-BA78-563540D0691BQ40082240-CB78EDF8-BF38-4D62-957C-DC483447470BQ40281016-D7B4D105-8E63-40EC-8C6D-020D4CEB59FAQ42490934-8932015C-7ED0-496B-BA80-89627439E170Q43241544-D51F5E66-BCB5-45AB-AD8F-CF939E2836CFQ44542402-B6038550-650C-4442-935C-1098987D5E23Q46266772-92B776CB-6D37-41DA-B70A-A3A8C56E3294Q46694374-B449E7FA-EDFB-451C-9DB4-A190031D7AF0Q47410183-08A9A312-2D0D-41F0-9E0C-53975234AB7E
P2860
Myoglobin as a model system for designing heme protein based blood substitutes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Myoglobin as a model system for designing heme protein based blood substitutes.
@ast
Myoglobin as a model system for designing heme protein based blood substitutes.
@en
type
label
Myoglobin as a model system for designing heme protein based blood substitutes.
@ast
Myoglobin as a model system for designing heme protein based blood substitutes.
@en
prefLabel
Myoglobin as a model system for designing heme protein based blood substitutes.
@ast
Myoglobin as a model system for designing heme protein based blood substitutes.
@en
P2093
P1476
Myoglobin as a model system for designing heme protein based blood substitutes.
@en
P2093
David H Maillett
Raymund F Eich
P304
P356
10.1016/S0301-4622(02)00090-X
P577
2002-07-01T00:00:00Z